Anti-Infective Drugs Market - Forecast(2022 - 2027)

Report Code: HCR 0149 Report Format: PDF + Excel

Anti-Infective Drugs Market Overview

Anti-Infective Drugs Market Size is estimated to reach $131 billion by 2027. Furthermore, it is poised to grow at a CAGR of 4.3% over the forecast period of 2022-2027. An infection is the intrusion of disease-causing pathogens into an organism's bodily tissues, their multiplication, and the host tissues' reaction to the infectious organisms and the toxins they release. Anti-infectives are medicines that work to inhibit the spread or treat infections. Anti-infectives majorly include antibiotics, antivirals, antifungals, and antiparasitic medications that destroy or inhibit the growth of bacteria, harmful viruses, fungal cells, and parasitic agents respectively. Anti candida drugs are a type of antifungal drug that is used to treat candidiasis, which is a fungal infection caused by yeast. Patients with Acute Respiratory Infections or a common cold commonly use nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and fever. NSAIDs’ side effects vary depending on the drug, but most commonly include an increased risk of gastrointestinal ulcers and bleeding heart stroke, and kidney disease. The growing prevalence of infectious diseases, increase in health consciousness and healthcare expenditure as well as increasing awareness and adoption about Anti-Infective Drugs are some of the factors driving the Anti-Infective Drugs Market growth during the forecast period 2022-2027.

Report Coverage

The report: “Anti-Infective Drugs Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Anti-Infective Drugs Market.

By Drug Type- Antibiotics, Antifungals, Antivirals, and others.
By Indication- HIV, Pneumonia, Tuberculosis, Respiratory Infections, Influenza and others.
By Route of Administration: Oral, Topical, and Parenteral.
By Distribution Channels- Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America held a dominant market share in the year 2021 on account of healthcare infrastructure which is well developed, skilled healthcare professionals, and consumers with high buying power. Asia-Pacific is expected to offer lucrative growth opportunities to the manufacturers owing to the rising awareness about the effectiveness of Anti-infective drugs and increasing demand for better healthcare medications and facilities. The robust growth of the antivirals segment is predicted to augment the market growth during the forecast period of 2022-2027.
  • An increasing geriatric population with a high risk of being susceptible to infectious diseases is estimated to drive the market growth of anti-infective drugs. The huge financial burden of R&D activities and the presence of substitutes in the market continues to pose threat to market growth.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Anti-Infective Drugs Market Report.

Anti-Infective Drugs Market: Market Share (%) by region, 2021

Anti-Infective Drugs Market

For more details on this report - Request for Sample

Anti-Infective Drugs Market Segmentation Analysis- By Drug Type

Anti-Infective Drugs Market based on drug type can be further segmented into Antibiotics, Antifungals, Antivirals, and others. Antiviral’s segment held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 4.6% over the forecast period of 2022-2027. Antiviral drugs are used to cure viral infections. Instead of killing their target pathogens, they inhibit their development. The increasing prevalence of HIV is one of the key factors driving the growth of the antivirals segment. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), there were approximately 37.7 million people across the globe with HIV in 2020. Antivirals work by preventing viruses from multiplying in the body, allowing the immune system to repair and prevent future damage. HIV can swiftly adapt and become resistant; a combination of HIV drugs is used. The global demand for antiviral drugs has risen substantially as a result of the COVID-19 epidemic. For instance, the FDA has approved the antiviral medication remdesivir for the treatment of COVID-19 in adults and children above 12 years. Rising investments in the development of antiviral drugs to treat covid and the increasing prevalence of other infectious diseases are estimated to augment the market growth over the forecast period.

Anti-Infective Drugs Market Segmentation Analysis- By Distribution Channels

Anti-Infective Drugs Market based on distribution channels type can be further segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. Hospital Pharmacies held a dominant market share in the year 2021 primarily owing to the increase in the number of people being hospitalized due to infectious diseases and rising demand for these drugs by medical professionals to treat the patients in a better way. The pandemic augmented the number of people who needed to be hospitalized. Governments in various countries are partnering with hospitals to increase the rate at which antiviral drugs are distributed to those who need them. For instance, Tamil Nadu (India) government, partnered up with private hospitals to provide anti-viral drug Remdesivir during the pandemic.

However, Online Pharmacies are estimated to be the fastest-growing, with a CAGR of 4.9% over the forecast period of 2022-2027 on account of lockdown restrictions owing to the pandemic and increasing use of the internet as well as smart gadgets. The expansion of the online pharmacies market is expected to be aided by the increasing global penetration of e-commerce. It is estimated that there were 2.14 billion worldwide digital buyers, and by 2040, 95 percent of all purchases will be made through eCommerce, propelling the rise of online pharmacies.

Anti-Infective Drugs Market Segmentation Analysis- By Geography

The Anti-Infective Drugs market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 41% in the year 2021 as compared to the other counterparts on account of well-developed healthcare infrastructure, increasing prevalence of infectious diseases, and higher purchasing power of the consumers. According to statistics given by the Canadian government, influenza and pneumonia are among the top 10 leading causes of death in the country. It is estimated that each year influenza causes approximately 12,200 hospitalizations and 3,500 fatalities in Canada.

However, Asia-Pacific is estimated to be the fastest-growing, with a CAGR of 5.4% over the forecast period of 2022-2027 on account of the increase in demand for better healthcare facilities, the rising awareness about the effectiveness of anti-infective drugs, and increased vulnerability to infectious diseases owing to the rising geriatric population. According to the United Nations Population Fund (UNFPA), in Asia and the Pacific, one in every four persons will be over 60 years old by 2050 in Asia and the Pacific. Between 2010 and 2050, the region's population of older people (those over 60) will triple, reaching about 1.3 billion individuals. Increased investments and developments in the pharmaceutical industry by both government and private players are estimated to augment the market growth during the forecast period.

Anti-Infective Drugs Market Drivers

The Increasing Prevalence of HIV and other infectious diseases have benefitted the consumption of anti-infective drugs

The human immunodeficiency virus (HIV) attacks the immune system, making people more vulnerable to infections. Acquired Immunodeficiency Syndrome (AIDS) can develop if HIV is not treated timely. According to The Joint United Nations Program on HIV/AIDS (UNAIDS), around1.5 a million individuals worldwide acquired HIV in 2020 alone. CD4 cells, which are also known as white blood cells, are damaged or destroyed by HIV. The body's ability to combat illness is hampered as a result of this. Antiviral drugs stop the virus from growing, which lowers the amount of HIV in the body and the immune system starts producing the cells again.

The increase in the prevalence of influenza is another key factor driving the market growth. Influenza is a communicable virus that can cause mild to moderate symptoms as well as severe complications, including death. According to the Centres for Disease Control and Prevention (CDC), 35.5 million persons were infected by influenza in 2018–2019, resulting in 490,600 hospitalizations and 34,200 fatalities, thereby augmenting the Anti-Infective Drugs Industry growth.

Increasing the Geriatric Population with a higher risk of being susceptible to infectious diseases is driving the market growth.

According to estimates of the World Health Organisation (WHO), by 2030, one in every six persons in the world will be 60 years old or more, and by 2050, the world population of people aged 60 years and older will get doubled (2.1 billion). Between 2020 and 2050, the number of people aged 80 and more is predicted to triple, reaching 426 million. The human immune system weakens with age, making it less effective at fighting illnesses and less responsive to vaccinations. The immune system's ability to distinguish self from foreign antigens deteriorates. T cells that remember antigens they've previously encountered become slower at responding to new antigens. People are more susceptible to infections as a result of a combination of increased comorbid diseases and decreased immune system activity, driving the market growth.

Anti-Infective Drugs Market Challenges

Huge Investment Costs in R&D activities of the anti-infective drugs are impeding the market growth.

Costs for discovering and testing new drugs, creating incremental innovations such as product expansions, and clinical testing for safety monitoring or marketing objectives are all included in drug manufacturers' R&D expenditures. Drug development is a time-consuming and uncertain process, and many potential drugs never reach the market due to complex approval processes. Increased AMR and a lack of investment in expensive last-stage R&D operations aimed to tackle it continue to pose a threat to market growth. AMR is when bacteria, viruses, fungi, and parasites develop over time and stop responding to medications, infections become more difficult to treat, and the risk of transmission of infection, severe illness, and death increases. According to the UN, AMR causes 700,000 fatalities each year, with that number expected to rise to 10 million by 2050 if no solutions are discovered, posing a threat to market growth.

Anti-Infective Drugs Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Anti-Infective Drugs Market. The top 10- Anti-Infective Drugs Market companies include:

  1. Novartis AG
  2. Merck & Co., Inc
  3.  Alcon Pharmaceuticals Ltd
  4. Quest Diagnostics Inc.
  5. AstraZeneca Plc
  6. Anofi SA
  7. GSK
  8. Gilead Sciences
  9. Novartis AG
  10. Cipla

Recent Developments

  • In August 2021, Xellia Pharmaceuticals, a pharmaceutical company specializing in anti-infective treatments, expanded its production capacity in Ohio. They released the first anti-infectives manufactured at the site for distribution to US hospitals.
  • In April 2021, Pfizer, a multinational pharmaceutical and biotechnology corporation, acquired Amplyx Pharmaceuticals, Inc., a company that develops therapies for debilitating and life-threatening diseases, and expanded its anti-infectives portfolio with the addition of Fosmanogepix, a novel antifungal Phase 2 candidate (APX001). Amplyx's early-stage portfolio, which includes antiviral (MAU868) and antifungal (APX2039) drugs, is now owned by Pfizer.
  • In October 2019, Cipla, an Indian multinational pharmaceutical company acquired a novel and patented anti-infective product, Elores, from Venus Remedies Ltd, a research and development-driven global pharmaceutical company. Elores is indicated for the treatment of life-threatening infections caused by gram-negative bacteria.

Relevant Titles

Generic Drugs Market
Report Code: HCR 0217

Hospital Supplies Market
Report Code: HCR 0180


For more Lifesciences and Healthcare related reports, please click here

1. Anti-Infective Drugs Market- Overview
    1.1 Definitions and Scope
2. Anti-Infective Drugs Market- Executive Summary
3. Anti-Infective Drugs Market- Comparative Analysis
    3.1 Company Benchmarking
    3.2 Global Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Anti-Infective Drugs Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Anti-Infective Drugs Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Anti-Infective Drugs Market- Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Anti-Infective Drugs Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Anti-Infective Drugs Market– By Drug Type
    8.1 Antibiotics
    8.2 Antifungals
    8.3 Antivirals
    8.4 Others 
9. Anti-Infective Drugs Market– By Indication 
    9.1 HIV
    9.2 Pneumonia
    9.3 Tuberculosis
    9.4 Respiratory Infections
    9.5 Influenza
    9.6 Others
10. Anti-Infective Drugs Market- By Route of Administration
    10.1 Oral
    10.2 Topical
    10.3 Parenteral
11. Anti-Infective Drugs Market- By Distribution Channels
    11.1 Hospital Pharmacies
    11.2 Retail Pharmacies
    11.3 Online Pharmacies
    11.4 Others
12. Anti-Infective Drugs Market- By Geography
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Anti-Infective Drugs Market- Entropy
14. Anti-Infective Drugs Market– Industry/Segment Competition Landscape Premium 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
    14.2 Competition Matrix
    14.3 Best Practices for Companies
15. Anti-Infective Drugs Market– Key Company List by Country Premium Premium
16. Anti-Infective Drugs Market - Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Anti-Infective Drugs Market Overview 2021-2026
Table 2: Anti-Infective Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Anti-Infective Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Anti-Infective Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Anti-Infective Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Anti-Infective Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Anti-Infective Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Anti-Infective Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Anti-Infective Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Anti-Infective Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Anti-Infective Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Anti-Infective Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Anti-Infective Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Anti-Infective Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Anti-Infective Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Anti-Infective Drugs Market Pricing Analysis 2021-2026 (US$)
Table 17: Anti-Infective Drugs Market Opportunities Analysis 2021-2026 (US$)
Table 18: Anti-Infective Drugs Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Anti-Infective Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Anti-Infective Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Anti-Infective Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Anti-Infective Drugs Market Size 2018 (US$)
Table 23: Anti-Infective Drugs Market Forecast Analysis 2021-2026 (US$)
Table 24: Anti-Infective Drugs Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 26: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antifungals, 2021-2026 ($)
Table 27: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Allylamines, 2021-2026 ($)
Table 28: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antibacterials, 2021-2026 ($)
Table 29: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Aminoglycosides, 2021-2026 ($)
Table 30: Anti-Infective Drugs Market By Drugs Type, Revenue & Volume,By Antivirals, 2021-2026 ($)
Table 31: Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 32: Anti-Infective Drugs Market By Infection, Revenue & Volume,By HIV, 2021-2026 ($)
Table 33: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Hepatitis B, 2021-2026 ($)
Table 34: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Hepatitis C, 2021-2026 ($)
Table 35: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Urinary Tract, 2021-2026 ($)
Table 36: Anti-Infective Drugs Market By Infection, Revenue & Volume,By Respiratory Candidiasis, 2021-2026 ($)
Table 37: North America Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 38: North America Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 39: South america Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 40: South america Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 41: Europe Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 42: Europe Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 43: APAC Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 44: APAC Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 45: Middle East & Africa Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 46: Middle East & Africa Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 47: Russia Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 48: Russia Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 49: Israel Anti-Infective Drugs Market, Revenue & Volume,By Drugs Type, 2021-2026 ($)
Table 50: Israel Anti-Infective Drugs Market, Revenue & Volume,By Infection, 2021-2026 ($)
Table 51: Top Companies 2018 (US$)Anti-Infective Drugs Market, Revenue & Volume
Table 52: Product Launch 2018-2019Anti-Infective Drugs Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Anti-Infective Drugs Market, Revenue & Volume


List of Figures

Figure 1: Overview of Anti-Infective Drugs Market 2021-2026
Figure 2: Market Share Analysis for Anti-Infective Drugs Market 2018 (US$)
Figure 3: Product Comparison in Anti-Infective Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Anti-Infective Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Anti-Infective Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Anti-Infective Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Anti-Infective Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Anti-Infective Drugs Market 2018
Figure 9: Average Selling Price in Anti-Infective Drugs Market 2021-2026
Figure 10: Top Opportunites in Anti-Infective Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Anti-Infective Drugs Market
Figure 12: GlobalBy Drugs TypeAnti-Infective Drugs Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy InfectionAnti-Infective Drugs Market Revenue, 2021-2026 ($)
Figure 14: Global Anti-Infective Drugs Market - By Geography
Figure 15: Global Anti-Infective Drugs Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Anti-Infective Drugs Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 18: US Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 93: China Anti-Infective Drugs Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Anti-Infective Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Anti-Infective Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Anti-Infective Drugs Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Anti-Infective Drugs Market 
Figure 131: Developments, 2018-2019*Anti-Infective Drugs Market 
Figure 132: Company 1 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Anti-Infective Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Anti-Infective Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Anti-Infective Drugs Market Net Sales Share, By Geography, 2018 (%)